Where to start? Mr. Golisano began to invest his money (Sept. 2011) and Mr. Kaplan his time (Oct. 2010) before the MyCadian technology was known. NB: I'm not diminishing Mr. Kaplan's open market purchases here; just simplifying for argument's sake. They were both attracted by the pump and differential tech.
Now your insidercow report. It tracks insider common purchases. So Mr. Golisano's $ 11.5 million investment as a 10% beneficial owner in the Series C and C-2 convertible preferreds in 2011 and 2014 would not be counted. Mr. Kaplan's stock option grant as CEO and director would not be counted. And alas, the approximate $ 550,000 money investment expected from insider officers and directors in the Series C-3 will not be counted - again because it's a convertible preferred. Big investment has and will be made by the insiders in the company but virtually all of it is not in (but convertible to) common.
Perhaps instead of granting Mr. Kaplan stock options in 2010, the company should have forgone R&D and instead funded a big salary for him. After a big tax bill, he could've used the residual to purchase common shares on the open market, and the insidercow numbers would be spectacular!